Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease.

Browning JD, Cohen JC, Hobbs HH.

Hepatology. 2010 Oct;52(4):1189-92. doi: 10.1002/hep.23946. No abstract available.

PMID:
20879029
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.

Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V.

Hepatology. 2010 Oct;52(4):1274-80. doi: 10.1002/hep.23823.

PMID:
20648474
[PubMed - indexed for MEDLINE]
3.

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.

Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ; NASH CRN.

Hepatology. 2010 Sep;52(3):894-903. doi: 10.1002/hep.23759.

PMID:
20684021
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Methodological concerns about a recent meta-analysis of the influence of the I148M variant of patatin-like phospholipase domain containing 3 on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Liu L, Shao JH, Wang K, Hua FZ.

Hepatology. 2011 Jun;53(6):2145; author reply 2146-7. doi: 10.1002/hep.24335. Epub 2011 May 2. No abstract available.

PMID:
21465506
[PubMed - indexed for MEDLINE]
5.

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Sookoian S, Pirola CJ.

Hepatology. 2011 Jun;53(6):1883-94. doi: 10.1002/hep.24283. Epub 2011 May 14. Review.

PMID:
21381068
[PubMed - indexed for MEDLINE]
6.

PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function?

Dubuquoy C, Burnol AF, Moldes M.

Clin Res Hepatol Gastroenterol. 2013 Feb;37(1):30-5. doi: 10.1016/j.clinre.2012.06.014. Epub 2012 Aug 11.

PMID:
22884299
[PubMed - indexed for MEDLINE]
7.

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.

Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C.

Hepatology. 2011 Jul;54(1):60-9. doi: 10.1002/hep.24350.

PMID:
21488075
[PubMed - indexed for MEDLINE]
8.

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.

Hotta K, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Chayama K, Nakajima A, Nakao K, Sekine A.

BMC Med Genet. 2010 Dec 22;11:172. doi: 10.1186/1471-2350-11-172.

PMID:
21176169
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Emerging genes associated with the progression of nonalcoholic fatty liver disease.

Koutsari C, Lazaridis KN.

Hepatology. 2010 Sep;52(3):807-10. doi: 10.1002/hep.23869. No abstract available.

PMID:
20812353
[PubMed - indexed for MEDLINE]
10.

The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.

Wang CW, Lin HY, Shin SJ, Yu ML, Lin ZY, Dai CY, Huang JF, Chen SC, Li SS, Chuang WL.

Liver Int. 2011 Oct;31(9):1326-31. doi: 10.1111/j.1478-3231.2011.02526.x. Epub 2011 Apr 5.

PMID:
21745282
[PubMed - indexed for MEDLINE]
11.

Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China.

Li Y, Xing C, Cohen JC, Hobbs HH.

Hepatology. 2012 Jan;55(1):327-8. doi: 10.1002/hep.24659. No abstract available.

PMID:
21898508
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.

He S, McPhaul C, Li JZ, Garuti R, Kinch L, Grishin NV, Cohen JC, Hobbs HH.

J Biol Chem. 2010 Feb 26;285(9):6706-15. doi: 10.1074/jbc.M109.064501. Epub 2009 Dec 23.

PMID:
20034933
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Common genetic variants and nonalcoholic Fatty liver disease.

Browning JD.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1191-3. doi: 10.1016/j.cgh.2013.05.013. Epub 2013 May 21. No abstract available.

PMID:
23707460
[PubMed - indexed for MEDLINE]
14.

Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.

Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S.

Hepatology. 2011 Mar;53(3):791-9. doi: 10.1002/hep.24123. Epub 2011 Feb 11.

PMID:
21319195
[PubMed - indexed for MEDLINE]
15.

Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.

Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, Königsrainer I, Königsrainer A, Schick F, Fritsche A, Häring HU, Stefan N.

Diabetes. 2009 Nov;58(11):2616-23. doi: 10.2337/db09-0279. Epub 2009 Aug 3.

PMID:
19651814
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.

Hyysalo J, Stojkovic I, Kotronen A, Hakkarainen A, Sevastianova K, Makkonen J, Lundbom N, Rissanen A, Krauss RM, Melander O, Orho-Melander M, Yki-Järvinen H.

J Gastroenterol Hepatol. 2012 May;27(5):951-6. doi: 10.1111/j.1440-1746.2011.07045.x.

PMID:
22141340
[PubMed - indexed for MEDLINE]
17.

[Genetic predisposition related to non-alcoholic fatty liver disease].

Miyamoto T, Ono M, Saibara T.

Nihon Shokakibyo Gakkai Zasshi. 2013 Sep;110(9):1597-601. Review. Japanese. No abstract available.

PMID:
24005099
[PubMed - indexed for MEDLINE]
18.

Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time!

Chalasani N.

Gastroenterology. 2009 Sep;137(3):772-5. doi: 10.1053/j.gastro.2009.07.032. Epub 2009 Jul 26. No abstract available.

PMID:
19638269
[PubMed - indexed for MEDLINE]
19.

APOC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air.

Duseja A, Aggarwal R.

J Gastroenterol Hepatol. 2012 May;27(5):848-51. doi: 10.1111/j.1440-1746.2012.07103.x. No abstract available.

PMID:
22369128
[PubMed - indexed for MEDLINE]
20.

LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease.

Valenti L, Motta BM, Alisi A, Sartorelli R, Buonaiuto G, Dongiovanni P, Rametta R, Pelusi S, Fargion S, Nobili V.

J Pediatr Gastroenterol Nutr. 2012 May;54(5):588-93. doi: 10.1097/MPG.0b013e3182442a55.

PMID:
22157924
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk